0.458
price up icon5.05%   +0.022
after-market  After Hours:  .458 
loading

Evoke Pharma Inc Stock (EVOK) Forecast

The Evoke Pharma Inc (EVOK) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $15.88, representing a +3,367% increase from the current price of $0.458. The highest analyst price target is $15.69, and the lowest is $16.07.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month EVOK Price Target
Average 9.693 (+2,016% Upside)
loading

Is Evoke Pharma Inc (EVOK) A Buy Now?

Oscillators
Name Value Action
RSI(14) 38.24 Neutral
STOCH(9,6) 20.13 Neutral
STOCHRSI(14) 51.92 Neutral
MACD(12,26) -0.0468 Sell
ADX(14) 13.67 Neutral
William %R -78.88 Neutral
CCI(14) -68.98 Neutral
Buy: 0 Sell: 1 Neutral: 6
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
0.4682
Sell
0.4728
Sell
MA20
0.5206
Sell
0.5089
Sell
MA50
0.5946
Sell
0.5972
Sell
MA100
0.7619
Sell
0.7516
Sell
MA200
1.0292
Sell
1.1234
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, EVOK could be considered a Strong Sell, with 17 technical analysis indicators signaling 0 Buy signals, 11 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on EVOK, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 38.24 indicates that EVOK is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 20.13 indicates that EVOK is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 51.92 indicates that EVOK is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 13.67 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -68.98 indicates that EVOK is still oversold but not to an extreme extent.

Long-term EVOK price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Evoke Pharma Inc financial reports and earnings history, Evoke Pharma Inc (EVOK) stock could reach $40.35 by 2030, $12.97 by 2040 and $48.81 by 2050. See the projected annual prices until 2050 of the Evoke Pharma Inc stock below:

  • Evoke Pharma Inc (EVOK) is expected to reach an average price of $2.8627 in 2035, with a high prediction of $3.2237 and a low estimate of $2.9661. This indicates an $525.04% rise from the last recorded price of $0.458.
  • Evoke Pharma Inc (EVOK) stock is projected to chart a bullish course in 2040, with an average price target of $12.59, representing an $2,648% surge from its current level. The forecast ranges from a conservative $12.32 to a sky-high $12.97.
  • Our analysts predict Evoke Pharma Inc (EVOK) to jump 6,200% by 2045, soaring from $28.97 to an average price of $28.85, potentially reaching $29.34. While $28.97 is the low estimate, the potential upside is significant.
  • Evoke Pharma Inc (EVOK) stock is expected to climb by 2050, reaching an average of $48.05, a $10,392% jump from its current level. However, a wide range of estimates exists, with high and low targets of $48.81 and $48.05, respectively, highlighting the market's uncertainty.

Evoke Pharma Inc Stock (EVOK) Year by Year Forecast

Evoke Pharma Inc Stock (EVOK) Price Forecast for 2024

Our forecast for EVOK stock price in 2024 now indicates an average price target of $9.5285 with a high forecast of $16.99 and a low forecast of $2.071. The average prediction reflects an increase of +1,980% from the last recorded price of $0.458.
Month Average Low High Change from today's price
May, 2024 $16.04 $16.07 $15.69 +3,403%
June, 2024 $16.54 $16.56 $16.99 +3,511%
July, 2024 $15.49 $16.35 $15.95 +3,282%
August, 2024 $11.57 $12.77 $11.71 +2,426%
September, 2024 $11.14 $12.46 $11.92 +2,332%
October, 2024 $11.75 $11.53 $11.08 +2,466%
November, 2024 $12.44 $12.06 $11.97 +2,616%
December, 2024 $8.818 $11.57 $11.76 +1,825%

Evoke Pharma Inc Stock (EVOK) Price Forecast for 2025

Evoke Pharma Inc Stock (EVOK) is expected to reach an average price of $27.94 in 2025, with a high prediction of $54.55 and a low estimate of $1.3205. This indicates an +5,999% rise from the last recorded price of $0.458.
Month Average Low High Change from today's price
January, 2025 $2.2354 $2.7154 $1.7733 +388.08%
February, 2025 $2.3716 $2.3999 $1.7375 +417.81%
March, 2025 $3.5006 $3.8797 $3.1418 +664.32%
April, 2025 $4.118 $3.3299 $3.158 +799.12%
May, 2025 $6.1141 $7.1341 $8.2673 +1,235%
June, 2025 $3.7043 $4.0303 $6.2422 +708.81%
July, 2025 $9.2395 $1.3205 $9.3595 +1,917%
August, 2025 $9.2233 $6.1374 $14.62 +1,914%
September, 2025 $27.23 $19.75 $41.11 +5,846%
October, 2025 $50.20 $22.79 $54.55 +10,860%
November, 2025 $47.90 $33.69 $52.20 +10,359%
December, 2025 $35.25 $34.41 $49.19 +7,597%

Evoke Pharma Inc Stock (EVOK) Price Forecast for 2026

The predicted value for Evoke Pharma Inc (EVOK) in 2026 is set at an average of $21.41. Estimates vary from a peak of $42.74 to a trough of $0.0856, indicating an +4,576% surge from the present price of $0.458.
Month Average Low High Change from today's price
January, 2026 $28.75 $28.03 $42.74 +6,178%
February, 2026 $19.74 $17.52 $29.80 +4,210%
March, 2026 $17.41 $15.76 $22.72 +3,701%
April, 2026 $18.11 $13.77 $28.11 +3,855%
May, 2026 $25.42 $14.24 $41.89 +5,449%
June, 2026 $7.9654 $6.1654 $26.66 +1,639%
July, 2026 $4.9493 $3.3893 $9.3501 +980.63%
August, 2026 $0.6991 $0.9809 $7.0412 +52.63%
September, 2026 $3.0829 $0.1522 $3.9229 +573.12%
October, 2026 $1.2667 $0.1733 $3.8548 +176.58%
November, 2026 $2.7765 $0.0873 $5.6565 +506.23%
December, 2026 $0.6003 $0.0856 $3.8093 +31.08%

Evoke Pharma Inc Stock (EVOK) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Evoke Pharma Inc (EVOK) is $32.57, with a high forecast of $65.07 and a low forecast of $0.0677. This indicates an +7,011% increase from the last price of $0.458.
Month Average Low High Change from today's price
January, 2027 $2.9842 $0.0677 $4.1842 +551.57%
February, 2027 $2.848 $1.3561 $5.0421 +521.84%
March, 2027 $2.7462 $0.3459 $4.3059 +499.61%
April, 2027 $4.35 $3.1126 $3.0984 +849.78%
May, 2027 $4.5634 $4.3324 $4.1945 +896.37%
June, 2027 $4.0816 $4.5088 $4.0586 +791.17%
July, 2027 $3.1905 $3.1601 $2.6129 +596.62%
August, 2027 $4.4311 $4.2771 $3.9403 +867.50%
September, 2027 $3.9673 $5.2513 $7.1927 +766.22%
October, 2027 $6.3835 $4.5713 $65.07 +1,294%
November, 2027 $5.7937 $6.0837 $6.3756 +1,165%
December, 2027 $5.3899 $5.4642 $5.3318 +1,077%

Evoke Pharma Inc Stock (EVOK) Price Forecast for 2028

In 2028, Evoke Pharma Inc (EVOK) is projected to reach an average price of $3.3209, with a high projection of $5.2386 and a low estimate of $1.4033. This indicates an +625.09% rise from the last price of $0.458.
Month Average Low High Change from today's price
January, 2028 $5.3501 $5.212 $5.2353 +1,068%
February, 2028 $5.3462 $5.2522 $5.1841 +1,067%
March, 2028 $5.4324 $5.4403 $5.2081 +1,086%
April, 2028 $5.2986 $5.3286 $5.2386 +1,057%
May, 2028 $5.0988 $5.1907 $5.1626 +1,013%
June, 2028 $3.635 $4.3651 $4.8229 +693.66%
July, 2028 $0.3052 $1.9552 $3.439 -33.37%
August, 2028 $2.6513 $1.4033 $2.2413 +478.89%
September, 2028 $1.5375 $2.3775 $2.351 +235.70%
October, 2028 $2.7677 $2.2216 $2.7337 +504.31%
November, 2028 $2.3755 $2.4089 $2.3358 +418.67%
December, 2028 $2.3651 $2.4201 $2.296 +416.39%

Evoke Pharma Inc Stock (EVOK) Price Forecast for 2029

The 2029 price forecast for Evoke Pharma Inc Stock (EVOK) is $20.18 on average, with a high prediction of $40.28 and a low estimate of $0.0735. This represents an +4,306% increase from the previous price of $0.458.
Month Average Low High Change from today's price
January, 2029 $1.8903 $2.0253 $2.2787 +312.72%
February, 2029 $1.6264 $1.6364 $1.7343 +255.12%
March, 2029 $1.8226 $1.6305 $1.6327 +297.95%
April, 2029 $1.4628 $1.4628 $1.5367 +219.39%
May, 2029 $0.824 $0.939 $0.8548 +79.91%
June, 2029 $0.5352 $0.667 $0.743 +16.85%
July, 2029 $0.1454 $0.1513 $0.2832 -68.26%
August, 2029 $22.98 $0.0735 $25.31 +4,917%
September, 2029 $18.45 $20.24 $21.37 +3,928%
October, 2029 $13.87 $15.19 $16.96 +2,929%
November, 2029 $34.50 $14.38 $33.40 +7,432%
December, 2029 $40.92 $34.20 $40.28 +8,834%

Evoke Pharma Inc Stock (EVOK) Price Forecast for 2030

Evoke Pharma Inc Stock (EVOK) is expected to reach an average price of $32.49 in 2030, with a high forecast of $41.29 and a low forecast of $23.70. This signifies an +6,995% surge from the last price of $0.458.
Month Average Low High Change from today's price
January, 2030 $40.94 $40.70 $40.35 +8,840%
February, 2030 $40.26 $40.59 $41.29 +8,689%
March, 2030 $39.28 $40.14 $39.94 +8,477%
April, 2030 $35.90 $35.92 $35.41 +7,739%
May, 2030 $34.15 $35.47 $35.11 +7,357%
June, 2030 $34.43 $34.46 $33.93 +7,417%
July, 2030 $34.19 $34.65 $34.39 +7,365%
August, 2030 $30.72 $33.64 $33.53 +6,607%
September, 2030 $24.70 $24.27 $23.59 +5,293%
October, 2030 $24.40 $23.70 $23.05 +5,228%
November, 2030 $24.28 $24.92 $23.92 +5,202%
December, 2030 $29.33 $23.94 $25.10 +6,303%
$13.26
price up icon 1.69%
$73.26
price up icon 1.57%
$55.92
price up icon 0.22%
drug_manufacturers_specialty_generic RDY
$74.55
price up icon 0.72%
$135.99
price down icon 1.28%
$11.57
price up icon 0.87%
Cap:     |  Volume (24h):